Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial

OBJECTIVES: To compare the efficacy and safety of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) for treating uncomplicated falciparum malaria in Uganda. DESIGN: Randomized single-blinded clinical trial. SETTING: Apac, Uganda, an area of very high malaria transmission intensity...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kamya, Moses R, Yeka, Adoke, Bukirwa, Hasifa, Lugemwa, Myers, Rwakimari, John B, Staedke, Sarah G, Talisuna, Ambrose O, Greenhouse, Bryan, Nosten, François, Rosenthal, Philip J, Wabwire-Mangen, Fred, Dorsey, Grant
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2007
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1876597/ https://ncbi.nlm.nih.gov/pubmed/17525792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pctr.0020020
Tags:	Add Tag No Tags, Be the first to tag this record!

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial

Similar Items